Published in 1851, The House of the Seven Gables was conceived by Nathaniel Hawthorne as a modern-day sequel to The Scarlet Letter, which had appeared the year before. Set in Salem, the story's dramatic center revolved around two elederly characters, Hepzibah and Clifford Pyncheon, as they struggle to free themselves from a centuries-old family curse, ghostly forebears, and a crippling sense of hereditary guilt. They find themselves aided in their quest by their young cousin, Phoebe, and a mysterious daguerreotypist named Holgrave, who has taken up residence with them. Watching over this human drama, as if awaiting its outcome, is the brooding House of the Seven Gables, the Pyncheon ancestral home.
In this book Hawthorne hoped to dispel the gloom of the Puritan past that pervades The Scarlet Letter. Whether or not he succeeded has long been a matter of opinion. Hawthorne's wife, Sophia, praised her husband's new romance for its "dear home-loveliness and satisfaction," while Herman Melville found it a damnably dark and subversive work: "[Hawthorne] says NO! in thunder; but the Devil himself cannot make him say yes."
About the Author
Nathaniel Hawthorne was born into an established New England Puritan family on Independence Day, 1804, in Salem, Massachusetts. Uninterested in conventional professions such as law, medicine, or the ministry, Nathaniel chose instead to rely "for support upon my pen." Hawthorne's coterie consisted of transcendentalist thinkers, including Ralph Waldo Emerson and Henry David Thoreau. Herman Melville had an early appreciation for the work of Hawthorne, but he did not gain wide public recognition until after his death. Although his Twice-Told Tales (1837) and other works met with little financial success, Hawthorne is credited, along with Edgar Allan Poe, with establishing the American short story.
Novelist and short story writer Nancy Stade (Introduction and Notes) is trained as a lawyer and has worked in the federal government and the private sector. She currently lives in Washington, D.C., where she works for the Federal Drug Administration.